Merdad V. Parsey

2020

In 2020, Merdad V. Parsey earned a total compensation of $7.2M as Chief Medical Officer at Gilead Sciences, a 130% increase compared to previous year.

Compensation breakdown

Bonus$1,000,000
Non-Equity Incentive Plan$1,794,000
Option Awards$1,000,033
Salary$1,038,462
Stock Awards$2,332,860
Other$15,000
Total$7,180,355

Parsey received $2.3M in stock awards, accounting for 32% of the total pay in 2020.

Parsey also received $1M in bonus, $1.8M in non-equity incentive plan, $1M in option awards, $1M in salary and $15K in other compensation.

Rankings

In 2020, Merdad V. Parsey's compensation ranked 1,350th out of 13,090 executives tracked by ExecPay. In other words, Parsey earned more than 89.7% of executives.

ClassificationRankingPercentile
All
1,350
out of 13,090
90th
Division
Manufacturing
491
out of 5,621
91st
Major group
Chemicals And Allied Products
172
out of 2,254
92nd
Industry group
Drugs
147
out of 1,954
93rd
Industry
Biological Products, Except Diagnostic Substances
42
out of 411
90th

Pay ratio

Merdad V. Parsey's Pay$7,180,355
Median Employee's Pay$250,190
Pay Ratio

29

to 1

In 2020, the annual total compensation of Merdad V. Parsey was $7,180,355.

The annual total compensation of the median employee at Gilead Sciences was $250,190.

The ratio of Merdad V. Parsey's pay to the pay of median employee was therefore 29 to one.

Source: SEC filing on March 30, 2021.

Parsey's colleagues

We found four more compensation records of executives who worked with Merdad V. Parsey at Gilead Sciences in 2020.

2020

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2020

Johanna Mercier

Gilead Sciences

Chief Commercial Officer

2020

Andrew Dickinson

Gilead Sciences

Chief Financial Officer

2020

Brett Pletcher

Gilead Sciences

General Counsel

News

You may also like